✦ LIBER ✦

SIMILARITY OF HEPATITIS FOLLOWING TRANSFUSION OF AUSTRALIA-ANTIGEN POSITIVE AND NEGATIVE BLOOD

✍ Scribed by Sutnick, AltonI.; Goeser, Eugene; Senior, JohnR.; Millman, Irving

Book ID: 122797915
Publisher: The Lancet
Year: 1973
Tongue: English
Weight: 798 KB
Volume: 302
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(73)92068-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-transfusion hepatitis type B follow

Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood

✍ Shubhangi Saraswat; Kakoli Banerjee; Navjyoti Chaudhury; Tekchand Mahant; Pramod 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Follow-Up of Blood Donors Positive for H

Follow-Up of Blood Donors Positive for Hepatitis B Surface Antigen

✍ H. W. Reesink; I. C. E. Wesdorp; R. Grijm; P. Hengeveld; A. C. Jöbsis; C. Aay; E 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

RAPID AND SIMULTANEOUS DETECTION OF SYPH

RAPID AND SIMULTANEOUS DETECTION OF SYPHILIS AND AUSTRALIA-ANTIGEN-POSITIVE BLOOD

✍ Fujita, Kimio; Takahashi, Matsuo 📂 Article 📅 1972 🏛 The Lancet 🌐 English ⚖ 121 KB

Prevention of post-transfusion hepatitis

Prevention of post-transfusion hepatitis: Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion

✍ Ronald L. Koretz; Gary L. Gitnck 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 763 KB

Australia Antigen and Posttransfusion He

Australia Antigen and Posttransfusion Hepatitis : A Study of Danish Blood Donors and Recipients

✍ V. Reinicke; O. Banke; E. Dybkjaer 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60